mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |